Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Cross-Sectional Study
98%
Malignant Neoplasm
79%
Prevalence
64%
Antiinfective Agent
64%
Diabetes Mellitus
56%
Antibiotics
54%
Warfarin
51%
Antimicrobial Resistance
48%
Cardiovascular Disease
38%
Bioavailability
37%
Infection
36%
microRNA
35%
Tablet
33%
Antioxidant
32%
Adverse Event
30%
Cohort Study
28%
Nanoparticle
28%
Global Disease Burden
28%
Comorbidity
27%
Anti-Inflammatory Drug
26%
Pharmacokinetic
26%
Inflammation
25%
Side Effect
24%
Retrospective Study
23%
Chitosan
23%
Coronavirinae
23%
Community Pharmacy
22%
Observational Study
20%
Vancomycin
20%
SARS Coronavirus
20%
Anticoagulant Agent
19%
Combination Therapy
19%
Pandemic
19%
Pharmacotherapy
18%
Chronic Disease
18%
Neoplasm
18%
Drug Release
17%
Breast Cancer
17%
Cyclodextrin
17%
Clinical Trial
16%
Drug Delivery System
15%
Drug Interaction
15%
Nanoemulsion
15%
Non Insulin Dependent Diabetes Mellitus
15%
Hydroxychloroquine
14%
Pharmacy Practice
14%
Differential Scanning Calorimetry
14%
Chemotherapy
14%
Syndrome
14%
Parkinson's Disease
14%
Reverse Phase High Performance Liquid Chromatography
14%
Nanomaterial
13%
Congestive Heart Failure
13%
Transcription Factor Nrf2
13%
Surgical Prophylaxis
13%
Adverse Drug Reaction
13%
Surgical Infection
13%
FDA Adverse Event Reporting System
13%
Hemoglobin A1c
13%
Dosage Form
13%
Pterostilbene
13%
Eudragit
13%
Resveratrol
12%
Cross Sectional Study
12%
Randomized Controlled Trial
12%
Inflammatory Arthritis
12%
Rheumatoid Arthritis
12%
Medication Error
12%
COVID-19 Vaccine
11%
Escherichia coli
11%
Piroxicam
11%
Gentamicin
11%
Curcumin
11%
CYP2C9
11%
Scanning Electron Microscopy
11%
IC50
11%
Controlled Release
11%
Atrial Fibrillation
11%
Silibinin
11%
Dexibuprofen
11%
Favipiravir
11%
Rosuvastatin
11%
Diabetic Cardiomyopathy
11%
Liver Cell Carcinoma
11%
Nanocomposite
11%
Phytochemical
11%
Polypharmacy
10%
Antidiabetic Agent
10%
Poloxamer
10%
Untranslated RNA
10%
Essential Oil
10%
Zeta Potential
10%
Toll Like Receptor 4
10%
Drug-Drug Interaction
10%
Doxorubicin
10%
Infectious Agent
10%
Superoxide Dismutase
10%
Antiapoptotic
9%
Liposome
9%
Nursing and Health Professions
Cross-Sectional Study
63%
Quality of Life
61%
Health Care Personnel
45%
Diseases
38%
Diabetes Mellitus
36%
Warfarin
28%
Antimicrobial Stewardship
28%
Systematic Review
19%
Medication Compliance
19%
Antimicrobial Resistance
17%
Tertiary Care Center
17%
Cohort Analysis
17%
Patient with Diabetes
17%
Antiinfective Agent
17%
Health Care Cost
16%
Rheumatoid Arthritis
14%
Inflammatory Arthritis
14%
Cost Effectiveness Analysis
14%
Prevalence
14%
Propensity Score
13%
Patient Compliance
12%
Intensive Care Unit
12%
Chronic Disease
12%
Meta Analysis
12%
Pharmacy Student
11%
Emergency Ward
11%
Blood Pressure
11%
Patient Attitude
11%
Health Care Utilization
11%
Health Care
11%
World Health Organization
10%
Patient with Type 2 Diabetes
10%
Cardiovascular Disease
10%
Medication Error
10%
General Practitioner
10%
Medication Therapy Management
9%
Primary Health Care
9%
Telemedicine
9%
Non Insulin Dependent Diabetes Mellitus
9%
Odds Ratio
8%
Inferential Statistics
8%
Anticoagulant Therapy
8%
Infection
8%
Drug Therapy
8%
Professional Standard
8%
Congestive Heart Failure
8%
Clinical Outcome
7%
Anticoagulation
7%
Comorbidity
7%
International Normalized Ratio
7%
Confidence Interval
7%
Polypharmacy
7%
Linear Regression Analysis
6%
Hemoglobin A1c
6%
Practice Guideline
6%
Multiple Linear Regression Analysis
6%
Malignant Neoplasm
6%
Hospital Readmission
5%
Anticoagulant Agent
5%
Hazard Ratio
5%
Patient-Reported Outcome
5%
Self Care
5%
Physical Disease by Body Function
5%
Sample Size
5%
Outpatient Department
5%
Logistic Regression Analysis
5%
Study Participant
5%
Medicine and Dentistry
COVID-19
39%
Malignant Neoplasm
29%
microRNA
25%
Diabetes
24%
Health Care Cost
23%
Diabetes Mellitus
21%
Global Disease Burden
18%
Programmed Cell Death
18%
Cancer Therapy
17%
Cross Sectional Study
16%
Diseases
15%
Tertiary Care
15%
Systematic Review
14%
Maturity Onset Diabetes of the Young
13%
Metastatic Carcinoma
13%
Cancer Cell
12%
Quality of Life
12%
Infection
12%
Neoplasm
12%
Retrospective Cohort Study
12%
Drug Therapy
11%
Breast Cancer
11%
Combination Therapy
10%
Antiinfective Agent
10%
Patient with Type 2 Diabetes
10%
Cardiovascular Disease
10%
Chronic Disease
9%
Prevalence
8%
Emergency Department
8%
Tumor Progression
8%
Pediatrics
8%
Hemoglobin A1c
8%
Patient with Diabetes
7%
Tocilizumab
7%
Odds Ratio
7%
COVID-19 Vaccination
7%
Primary Health Care
7%
Prostate Cancer
7%
Cardiovascular System
7%
Hepatocellular Carcinoma
7%
Exosome
7%
Complementary and Alternative Medicine
7%
Ophthalmology
7%
Lung Cancer
7%
Epithelial Mesenchymal Transition
7%
Health Care
6%
Antibiotics
6%
Propensity Score Matching
6%
Apoplexy
6%
Insulin Resistance
6%
Cell Death
6%
Health Care Management
6%
Polycystic Ovarian Syndrome
6%
Pediatrics Patient
6%
Medicine
5%
Antibiotic Resistance
5%
Retrospective Study
5%
Acute Myeloid Leukemia
5%
Angiogenesis
5%
Autophagy
5%
Patient Care
5%
Phytochemical
5%
Polycystic Ovary Syndrome
5%
Public Health
5%
Cancer
5%
Pathogen
5%
Counseling
5%
Community Pharmacy
5%
Anticarcinogen
5%
Virus
5%